US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.340
  • +0.330+16.42%
Close Nov 6 16:00 ET
  • 2.380
  • +0.040+1.71%
Post 17:35 ET
287.06MMarket Cap-2752P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mersana Therapeutics Q3 2024 Estimates Date

Currency：USDNov 13, 2024

Estimate YoY
Revenue
7.56M
-1.77%
EPS
-0.17
+50.50%
Analyst Rating
Strong Buy

Nov 6, 2024

Mersana Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 6.351M --
Nov 13, 2024 2024/Q3 -- / 7.562M --
Aug 13, 2024 2024/Q2 2.293M / 8.721M --
May 9, 2024 2024/Q1 9.245M / 8.289M --
Feb 28, 2024 2023/Q4 10.701M / 14.772M --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.351M--
Nov 13, 20242024/Q3-- / 7.562M--
Aug 13, 20242024/Q22.293M / 8.721M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--

Unlock Free Earnings Estimates

Mersana Therapeutics Earnings Reports

  • Mersana Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 21:02

  • Mersana Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 21:02

  • Mersana Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 21:52

  • Mersana Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 21:42

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data